WASHINGTON — The Department of Health and Human Services on Wednesday announced several initiatives to try and reduce reliance on animal testing in drug development.
The Food and Drug Administration released guidance meant to help drug companies explore new ways to assess the safety and efficacy of their products without using animals. And the National Institutes of Health said it has offered more than $150 million to institutions working on new research methods that better simulate human biology.
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA
announced
it would phase out the animal testing requirement for monoclonal antibodies. A few months later, the NIH said it would
no longer fund research projects
that rely solely on animal testing.
Continue to STAT+ to read the full story…
— Source: STAT News (https://www.statnews.com/2026/03/18/fda-nih-reduce-animal-testing-drug-development/)
